Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Risk of Attention Deficit Hyperactivity Disorder (ADHD) in the Children of Adults With ADHD Not Otherwise Specified (NOS)
A completed clinical trial examined whether children of adults with attention deficit hyperactivity disorder (ADHD NOS) have an increased ri…
-
CLINICAL_TRIALS trial_result · 2013-10-30Clinical Trial Update: Adult Normative Performance of the Quotient ADHD System
This document reports results from a completed clinical trial evaluating the adult normative performance of the Quotient ADHD System.
-
FDA approval · 2013-10-25FDA Approved: RITALIN — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for RITALIN (methylphenidate hydrochloride) from Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Sleepiness and Driving Performances in Adults With Attention-Deficit/ Hyperactivity Disorder (ADHD) [NA]
This entry notes the completion of a clinical trial evaluating sleepiness and driving performance in adults with attention-deficit/hyperacti…
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder [Phase 4]
Phase 4 clinical trial update evaluating Concerta for ADHD in youth and adults with Bipolar Disorder. The study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: Healthy Lifestyle in Adults With Attention Deficit Hyperactivity Disorder
This update notes that a trial assessing the impact of a healthy lifestyle intervention in adults with Attention Deficit Hyperactivity Disor…
-
CLINICAL_TRIALS research · 2013-10-14Clinical Trial Update: Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment [NA]
Hadassah Medical Organization is conducting a study to identify characteristic signatures of Attention Deficit Hyperactivity Disorder and to…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study) [Phase 4]
Phase 4 clinical trial comparing newer ADHD treatments with older options has completed; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: Effects of Using Betahistine to Treat Adults With Attention Deficit Hyperactivity Disorder [Phase 1]
Phase 1 clinical trial evaluating betahistine for treating adults with attention-deficit/hyperactivity disorder has completed.
-
FDA approval · 2013-09-25FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for a generic fixed-combination amphetamine product containing dextroamphetamine saccharate, am…
-
CLINICAL_TRIALS withdrawal · 2013-09-24Clinical Trial Update: Memantine Monotherapy for Executive Dysfunction and ADHD [NA]
The clinical trial evaluating memantine monotherapy for ADHD with executive function deficits has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-09-23Clinical Trial Update: Chantix in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 4]
Phase 4 evaluation of Chantix (varenicline) for smoking cessation in adults with ADHD; the trial was terminated and results were posted in 2…
-
FDA approval · 2013-09-23FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Lannett Company, Inc.)
The FDA approved Lannett Company's original application for methylphenidate hydrochloride, enabling the marketing of a generic methylphenida…
-
FDA approval · 2013-09-19FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Cranbury Pharmaceuticals, LLC)
The FDA approved a supplemental application for methylphenidate hydrochloride submitted by Cranbury Pharmaceuticals, LLC. The approval confi…
-
CLINICAL_TRIALS trial_result · 2013-09-13Clinical Trial Update: Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) [Phase 2]
Phase 2 study of TC-5619 in adults with attention-deficit/hyperactivity disorder evaluates efficacy, safety, and tolerability. The trial has…
-
CLINICAL_TRIALS trial_result · 2013-09-06Clinical Trial Update: An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of JNS001 in adults with Attention-Deficit Hyperactivity Disorder; results were po…
-
CLINICAL_TRIALS trial_result · 2013-09-06Clinical Trial Update: Pilot Study Of Primary And Secondary Attention-Deficit/Hyperactivity Disorder Among Survivors Of Childhood Cancer
This document provides an update on a pilot study evaluating primary and secondary Attention-deficit/hyperactivity disorder among survivors …
-
CLINICAL_TRIALS research · 2013-09-02Clinical Trial Update: Female Experiences and Brain Activity
A completed clinical trial update from King's College London investigating female experiences and brain activity in Attention Deficit Hypera…
-
FDA approval · 2013-08-23FDA Approved: INTUNIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Intuniv (guanfacine) from Takeda Pharmaceuticals America, Inc., updating the label for its u…
-
CLINICAL_TRIALS trial_result · 2013-08-23Clinical Trial Update: Effectiveness of an Extended Release Stimulant Medication in Treating Preschool Children With ADHD [NA]
A completed study evaluated the effectiveness of an extended-release stimulant medication for treating preschool children with attention-def…
-
FDA approval · 2013-08-09FDA Approved: QUILLIVANT XR — Supplemental Application (NextWave Pharmaceuticals, Inc)
The FDA approved a supplemental application for QUILLIVANT XR (methylphenidate hydrochloride) from NextWave Pharmaceuticals, expanding the r…
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I [NA]
A clinical trial evaluating a psychosocial treatment for Attention-deficit/hyperactivity disorder has completed.
-
FDA approval · 2013-08-07FDA Approved: ATOMOXETINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for atomoxetine by Zydus Pharmaceuticals USA Inc., marking an approved change to this generic ADHD m…
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: RCT, Proof of Concept Study of TEAMS (Training Executive, Attention and Motor Skills) Intervention Program [NA]
A randomized controlled trial and proof-of-concept study evaluating the TEAMS program, a training intervention targeting executive function,…
-
FDA approval · 2013-08-05FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for STRATTERA (atomoxetine hydrochloride) filed by Eli Lilly and Company to update the product l…